The comparison of BAL (2, 3-dimercaptopropanol) and Ca EDTA (calcium ethylene diamine tetra acetate) in the treatment of lead encephalopathy.
D002136:Calcium, Dietary; D004112:Dimercaprol / Q000627:therapeutic use*; D004492:Edetic Acid / Q000627:therapeutic use*; D005030:Ethylenes; D006801:Humans; D007855:Lead Poisoning / Q000150:complications*; D001523:Mental Disorders; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D011618:Psychotic Disorders
D002136:Calcium, Dietary; D005030:Ethylenes; D004112:Dimercaprol; D004492:Edetic Acid
DIMERCAPROL/therapeutic use; EDATHAMIL/therapeutic use; LEAD POISONING/complications; PSYCHOSES, TOXIC/etiology and pathogenesis